Skip to content

Clinical trials

Dyslipidemias trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Country / region: Czechia Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20068
20071
20101
20123
20132
20141
20161
20172
20201
20212
20222
20232
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Active, not recruiting2
Terminated2
Enrolling by invitation1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda8
Novartis Pharmaceuticals4
Amgen3
AstraZeneca3
89bio, Inc.2
NewAmsterdam Pharma2
Abbott1
Boehringer Ingelheim1
Charles University, Czech Republic1
Genentech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias31
Hypercholesterolemia10
Glucose Metabolism Disorders8
Diabetes Mellitus7
Diabetes Mellitus, Type 27
Hyperlipidemias6
Cardiovascular Diseases4
Lipid Metabolism Disorders4
Hyperlipoproteinemia Type II3
Hypertriglyceridemia3

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.